Novavax (UK) Price Prediction
| 0A3S Stock | 11.90 3.06 34.62% |
Oversold Vs Overbought
38
Oversold | Overbought |
Quarterly Earnings Growth 0.709 | Quarterly Revenue Growth (0.55) |
Using Novavax hype-based prediction, you can estimate the value of Novavax from the perspective of Novavax response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Novavax to buy its stock at a price that has no basis in reality. In that case, they are not buying Novavax because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Novavax after-hype prediction price | USD 11.9 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Novavax |
Novavax After-Hype Price Prediction Density Analysis
As far as predicting the price of Novavax at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Novavax or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Novavax, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Novavax Estimiated After-Hype Price Volatility
In the context of predicting Novavax's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Novavax's historical news coverage. Novavax's after-hype downside and upside margins for the prediction period are 0.60 and 24.67, respectively. We have considered Novavax's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Novavax is risky at this time. Analysis and calculation of next after-hype price of Novavax is based on 3 months time horizon.
Novavax Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Novavax is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Novavax backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Novavax, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.77 | 12.77 | 0.52 | 1.59 | 3 Events / Month | 2 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
11.90 | 11.90 | 0.00 |
|
Novavax Hype Timeline
Novavax is presently traded for 11.90on London Exchange of UK. The entity has historical hype elasticity of -0.52, and average elasticity to hype of competition of 1.59. Novavax is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is presently at 0.77%. %. The volatility of related hype on Novavax is about 619.9%, with the expected price after the next announcement by competition of 13.49. About 60.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 17.51. Novavax had not issued any dividends in recent years. The entity had 0.05:1 split on the 10th of May 2019. Assuming the 90 days trading horizon the next projected press release will be in about 3 days. Check out Novavax Basic Forecasting Models to cross-verify your projections.Novavax Related Hype Analysis
Having access to credible news sources related to Novavax's direct competition is more important than ever and may enhance your ability to predict Novavax's future price movements. Getting to know how Novavax's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Novavax may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TMIP | Taylor Maritime Investments | (2.00) | 1 per month | 0.00 | (0.16) | 2.60 | (2.53) | 6.90 | |
| 0RQ6 | Evolution Gaming Group | (5.04) | 1 per month | 0.00 | (0.14) | 1.57 | (2.59) | 17.26 | |
| BMY | Bloomsbury Publishing Plc | 33.81 | 1 per month | 0.00 | (0.1) | 3.61 | (3.25) | 13.25 | |
| 0K2K | Molson Coors Beverage | 0.66 | 4 per month | 1.08 | 0.06 | 2.81 | (2.04) | 9.53 | |
| 0K76 | New Residential Investment | 0.05 | 1 per month | 0.00 | (0.14) | 1.86 | (1.32) | 6.93 | |
| INV | The Investment | 1.00 | 2 per month | 0.27 | (0.17) | 1.35 | (0.80) | 2.70 | |
| LORD | Lords Grp Trading | 0.00 | 2 per month | 0.00 | (0.17) | 2.70 | (3.95) | 18.08 | |
| FEVR | Fevertree Drinks Plc | (12.00) | 1 per month | 0.00 | (0.21) | 2.98 | (3.32) | 14.39 |
Novavax Additional Predictive Modules
Most predictive techniques to examine Novavax price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Novavax using various technical indicators. When you analyze Novavax charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Novavax Predictive Indicators
The successful prediction of Novavax stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Novavax, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Novavax based on analysis of Novavax hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Novavax's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Novavax's related companies.
Story Coverage note for Novavax
The number of cover stories for Novavax depends on current market conditions and Novavax's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Novavax is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Novavax's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.